
Metoprolol tartrate is a selective beta-1 adrenoreceptor blocking agent used extensively in pharmaceutical manufacturing to manage hypertension, angina pectoris, and heart failure
In modern cardiology, the precision of beta-blockade is paramount for patient safety and efficacy. Manufacturers specifically select Metoprolol tartrate because of its proven track record in reducing blood pressure and myocardial oxygen demand. For instance, it is a global standard for the immediate treatment of hypertension and the prevention of secondary myocardial infarction. Consequently, it ensures stable cardiac rhythm management in acute healthcare environments. As a result, Zyntex ensures that our industrial-grade material meets strict international pharmacopoeial standards to guarantee potency in every formulation.
Moreover, Metoprolol tartrate is a primary component in the development of multi-ingredient cardiovascular therapies and liquid injectable forms. In the synthesis of these liquid dosages, Ethanol is often utilized as a high-purity solvent or co-solvent to achieve the desired concentration and stability. This application allows for the creation of targeted delivery systems with rapid onset of action. Undoubtedly, this pushes the boundaries of emergency cardiac care. At the same time, oral formulations often require specialized excipients for stability. For chewable or liquid oral preparations that require non-cariogenic properties, Xylitol is frequently integrated as a functional sweetener. In short, our product serves as a dependable building block for a wide array of heart health solutions.
Recently, scientific interest has focused on the metabolic interactions between beta-blockers and essential nutrients in the vascular system. Researchers apply Metoprolol tartrate in complex laboratory models, sometimes investigating its efficacy alongside antioxidants like Vitamin C (Ascorbic Acid) to study the combined effects on endothelial function and oxidative stress reduction. Because of this, Zyntex offers specialized, moisture-protected packaging to ensure the integrity of the tartrate salt during long-term storage. Ultimately, you secure a reliable supply partner by choosing Zyntex. We balance technical pharmaceutical expertise with rigorous quality control. To conclude, our commitment to chemical excellence ensures that your manufacturing processes achieve the highest levels of therapeutic reliability.
This high-performance beta-blocker is specifically vital in the following four sectors:
Zyntex supplies Metoprolol tartrate for hypertension and angina medications; thus supporting critical heart health management.
Used as an active agent in tablets and injections; consequently it is a staple in high-volume drug manufacturing.
Manufacturers use it for pharmacodynamic studies; undoubtedly essential for exploring new cardiovascular treatment pathways.
Zyntex provides high-purity API for acute care formulations; specifically aiding in emergency heart rate stabilization.
| Parameter | Standard Value |
|---|---|
| Product Name | Metoprolol tartrate (API Grade) |
| Assay (Purity) | Min. 99% |
| Appearance | White crystalline powder |
| CAS Number | 56392-17-7 |
⚠️ Safety & Handling: Metoprolol tartrate should be handled in a controlled pharmaceutical environment. Therefore, use protective equipment to prevent inhalation or skin contact. Store in a cool, dry place protected from light and moisture.
For more detailed pharmacokinetics and chemical property profiles, visit: PubChem Database – Metoprolol tartrate (56392-17-7)